A pioneering R&D project led by Telum Therapeutics, in collaboration with the Complutense University of Madrid (UCM) and the Carlos III Health Institute (ISCIII), has

Telum is pleased to announce the filing of a new patent for Telum’s proprietary modular library cloning system. This patent represents a significant advancement in

Pamplona, Spain – December 24, 2024– Telum Therapeutics, a leading biotechnology company specializing in drug discovery, is pleased to announce the filing of a new patent,